Agilon Health (NYSE:AGL) Stock Price Crosses Above 50-Day Moving Average – What’s Next?

Agilon Health, Inc. (NYSE:AGL)’s stock price passed above its 50 day moving average during trading on Tuesday. The stock has a 50 day moving average of $87.43 and traded as high as $91.11. Agilon Health shares last traded at $87.5340, with a volume of 329,712 shares changing hands.

Wall Street Analyst Weigh In

AGL has been the subject of a number of recent analyst reports. Truist Financial set a $112.00 price target on shares of Agilon Health and gave the company a “hold” rating in a research report on Thursday, August 6th. Sanford C. Bernstein upgraded Agilon Health from a “market perform” rating to an “outperform” rating and increased their price objective for the stock from $86.00 to $125.00 in a research report on Tuesday, September 15th. Royal Bank Of Canada set a $125.00 price objective on Agilon Health in a research note on Tuesday, September 15th. Wells Fargo & Company restated an “overweight” rating and set a $146.00 target price (up from $141.00) on shares of Agilon Health in a research report on Tuesday, August 11th. Finally, Barclays set a $111.00 target price on Agilon Health and gave the stock an “equal weight” rating in a research note on Thursday, August 6th. Six analysts have rated the stock with a Buy rating, six have given a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $102.25.

Agilon Health Stock Performance

The company has a current ratio of 1.08, a quick ratio of 1.08 and a debt-to-equity ratio of 0.07. The company’s fifty day moving average is $87.43 and its 200 day moving average is $65.50. The company has a market cap of $1.47 billion, a P/E ratio of -6.13 and a beta of 3.10.

Agilon Health (NYSE:AGL) last posted its quarterly earnings results on Wednesday, August 5th. The company reported $1.04 earnings per share for the quarter, topping the consensus estimate of $0.14 by $0.90. The business had revenue of $1.49 billion during the quarter, compared to the consensus estimate of $1.45 billion. Agilon Health had a negative net margin of 3.92% and a negative return on equity of 119.38%. As a group, equities analysts predict that Agilon Health, Inc. will post -2.90 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of AGL. Brighton Jones LLC purchased a new position in shares of Agilon Health in the third quarter worth about $288,000. Sterling Capital Management LLC purchased a new stake in Agilon Health during the 3rd quarter valued at about $33,000. Inspire Investing LLC boosted its holdings in Agilon Health by 31.2% during the 3rd quarter. Inspire Investing LLC now owns 8,048 shares of the company’s stock valued at $641,000 after acquiring an additional 1,912 shares during the period. Root Financial Partners LLC purchased a new stake in Agilon Health during the 3rd quarter valued at about $57,000. Finally, Counterpoint Mutual Funds LLC bought a new position in Agilon Health during the 3rd quarter worth approximately $273,000.

About Agilon Health

Agilon Health, Inc is a healthcare company that partners with independent primary care physicians to support the transition from fee-for-service medicine to value-based care. The company works with physician practices serving primarily older adults enrolled in Medicare Advantage and helps them manage the cost, quality and coordination of care for their patient populations.

Agilon provides a technology-enabled platform that includes population health analytics, clinical and administrative support, care coordination resources and practice-management capabilities.